Read the full article here.
This content was originally published by BusinessLIVE. Original publishers retain all rights. It appears here for a limited time before automated archiving. By BusinessLIVE
Pfizer, working with BioNtech, says it could make millions of doses this year and hundreds of millions in 2021, it it succeeds with one of its vaccine candidates